CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Services-Commercial Physical & Biological Research- 売上
- $4.0bn
- 時価総額
- $12.0bn
株価 $234.62 · 100株 2万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $4.1bn | $4.0bn | $4.0bn |
| 成長率 | — | ▲1.9% | ▲0.9% |
| 総利益 | $3.8bn | $3.8bn | $3.7bn |
| 総利益率 | 93.0% | 92.8% | 92.8% |
| 販管費 | $748m | $751m | $743m |
| 販管費率 | 18.1% | 18.5% | 18.5% |
| 営利 | $617m | $227m | $25m |
| 営利率 | 14.9% | 5.6% | 0.6% |
| 純利益 | $475m | $22m | ▲$144m |
| PBR | 3.3 | 3.5 | 3.8 |
| PSR | 2.9 | 3.0 | 3.0 |
| PGPR | 3.1 | 3.2 | 3.2 |
| PER | 25 | 540 | — |
| ﾈｯﾄｷｬｯｼｭ | ▲$2.4bn | ▲$2.0bn | ▲$1.9bn |
| EV/EBITDA | 15.4 | 23.8 | 32.5 |
| Rule of 40 | — | 4% | ▲0% |
| セールス効率 | — | ▲2,529% | — |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）